Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.

Revenue
−1.68%
EPS
+133.3%
Free cash flow
+88.9%

Quarter to September 2026, against a year earlier

39.72 2.37 −5.63%
Market cap
$2.5B
P/E
37.8×
Fwd P/E
33.3×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a
Sep '26 From the 10-Q filed 5 Nov Jun '26 Mar '26 Dec '25 Older periods
ROE
31.47% 30.14% 26.83% 26.76%

+8 more TTM periods

ROA
16.96% 16.48% 13.95% 13.42%
ROIC
36.76% 31.82% 28.86% 29.83%
Return on Tangible Assets
43.18% 41.94% 40.43% 42.27%
Average Days of Receivables
26.97 25.88 28.00 25.60
Free Cash Flow per Share
0.00 1.26 1.11 1.29
Free Cash Flow
114.06 79.79 70.28 80.71
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026